T1	PROC 60 71	TRATAMIENTO
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	CHEM 76 95	AGENTES ANTIVIRALES
#2	AnnotatorNotes T2	C0003451; Antiviral Agents; Pharmacologic Substance
T3	ANAT 119 129	GLOMERULAR
#3	AnnotatorNotes T3	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
T4	DISO 157 182	HEPATITIS CRÓNICA POR VHC
#4	AnnotatorNotes T4	C0524910; Hepatitis C, Chronic; Disease or Syndrome
T5	PROC 205 233	ENSAYO CLINICO MULTICENTRICO
T6	PROC 269 280	TRATAMIENTO
#5	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	CHEM 285 304	AGENTES ANTIVIRALES
#6	AnnotatorNotes T7	C0003451; Antiviral Agents; Pharmacologic Substance
T8	ANAT 328 338	GLOMERULAR
#7	AnnotatorNotes T8	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
T9	DISO 366 391	HEPATITIS CRÓNICA POR VHC
#8	AnnotatorNotes T9	C0524910; Hepatitis C, Chronic; Disease or Syndrome
T10	DISO 415 426	Hepatitis C
#9	AnnotatorNotes T10	C0019196; Hepatitis C; Disease or Syndrome
T11	DISO 469 494	hepatitis crónica por VHC
#10	AnnotatorNotes T11	C0524910; Hepatitis C, Chronic; Disease or Syndrome
T12	DISO 542 550	fibrosis
#11	AnnotatorNotes T12	C0016059; Fibrosis; Pathologic Function
T13	CHEM 556 566	sofosbuvir
#12	AnnotatorNotes T13	C2976303; sofosbuvir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T14	CHEM 633 643	ribavirina
#13	AnnotatorNotes T14	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T15	PROC 698 717	Filtrado glomerular
#14	AnnotatorNotes T15	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T16	PROC 858 871	procedimiento
#15	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T17	DISO 912 931	Coinfección con VHD
T18	DISO 933 954	virus hepatitis delta
T19	DISO 962 979	virus hepatitis C
T20	DISO 1056 1071	descompensación
#16	AnnotatorNotes T20	C0231187; Decompensation; Finding
T21	DISO 1073 1080	ascitis
#17	AnnotatorNotes T21	C0003962; Ascites; Disease or Syndrome
T22	DISO 1082 1085	HDA
#18	AnnotatorNotes T22	C0041909; Upper gastrointestinal hemorrhage; Pathologic Function
T23	DISO 1087 1100	encefalopatía
#19	AnnotatorNotes T23	C0006111; Brain Diseases; Disease or Syndrome | C0085584; Encephalopathies; Disease or Syndrome
T24	PROC 1122 1133	Diagnóstico
#20	AnnotatorNotes T24	C0011900; Diagnosis; Diagnostic Procedure
T25	DISO 1137 1140	CHC
#21	AnnotatorNotes T25	C2239176; Liver carcinoma; Neoplastic Process
T26	DISO 1142 1165	Carcinoma Hepatocelular
#22	AnnotatorNotes T26	C2239176; Liver carcinoma; Neoplastic Process
T27	PROC 1171 1182	Diagnostico
#23	AnnotatorNotes T27	C0011900; Diagnosis; Diagnostic Procedure
T28	DISO 1186 1202	crioglobulinemia
#24	AnnotatorNotes T28	C0010403; Cryoglobulinemia; Disease or Syndrome
T29	DISO 1205 1222	Diabetes mellitus
#25	AnnotatorNotes T29	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T30	PROC 580 590	regimen 3D
#26	AnnotatorNotes T30	[dasabuvir ombitasvir paritaprevir regime]
T31	PROC 1309 1328	trasplante hepático
#27	AnnotatorNotes T31	C0023911; Transplantation of liver; Therapeutic or Preventive Procedure
T32	PROC 1347 1356	plaquetas
#28	AnnotatorNotes T32	C0032181; Platelet Count measurement; Laboratory Procedure
T33	PROC 749 781	Consentimiento informado escrito
#29	AnnotatorNotes T33	C0811741; Obtain informed written consent; Health Care Activity
T34	PROC 650 669	esquema terapeútico
T35	CHEM 1434 1454	agentes nefrotóxicos
T36	PROC 1514 1532	exploración física
#30	AnnotatorNotes T36	C0031809; Physical Examination; Health Care Activity
T37	PROC 1569 1586	análisis clínicos
#31	AnnotatorNotes T37	C0376583; Clinical Laboratory Techniques; Health Care Activity
T38	CHEM 1701 1725	fármaco en investigación
#32	AnnotatorNotes T38	C0013230; Investigational New Drugs; Pharmacologic Substance
T39	CHEM 1776 1783	fármaco
#33	AnnotatorNotes T39	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T40	PROC 1823 1847	consentimiento informado
#34	AnnotatorNotes T40	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T41	DISO 983 986	VIH
#35	AnnotatorNotes T41	C0458074; Human immunodeficiency virus (HIV) status; Finding
T42	DISO 988 1021	virus de inmunodeficiencia humana
#36	AnnotatorNotes T42	C0458074; Human immunodeficiency virus (HIV) status; Finding
T43	ANAT 1152 1165	Hepatocelular
#37	AnnotatorNotes T43	C0227525; Hepatocyte; Cell
T44	DISO 1225 1243	Ingesta de alcohol
T45	PROC 1026 1035	Fibroscan
#38	AnnotatorNotes T45	C4522043; Liver Ultrasonographic Elastography; Diagnostic Procedure
T46	ANAT 1320 1328	hepático
#39	AnnotatorNotes T46	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T47	PROC 1366 1377	hemoglobina
#40	AnnotatorNotes T47	C0518015; Hemoglobin measurement; Laboratory Procedure
T48	PROC 1389 1397	albúmina
#41	AnnotatorNotes T48	C0201838; Albumin measurement; Laboratory Procedure
T49	PROC 1407 1418	bilirrubina
#42	AnnotatorNotes T49	C0863174; Blood bilirubin measurement; Laboratory Procedure
T50	PROC 1757 1783	administración del fármaco
#43	AnnotatorNotes T50	C3469597; Administration of medication; Therapeutic or Preventive Procedure
T51	CHEM 567 577	ledipasvir
#44	AnnotatorNotes T51	C3851350; ledipasvir; Organic Chemical · Pharmacologic Substance
T52	DISO 957 960	VHB
#45	AnnotatorNotes T52	C0019163; Hepatitis B; Disease or Syndrome
T53	Date 13 17	2016
T54	LIVB 143 152	PACIENTES
#46	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Duration 167 174	CRÓNICA
#47	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	LIVB 179 182	VHC
#48	AnnotatorNotes T56	C0220847; hepatitis C virus; Virus
T57	LIVB 352 361	PACIENTES
#49	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Duration 376 383	CRÓNICA
#50	AnnotatorNotes T58	C0205191; chronic; Temporal Concept
T59	LIVB 388 391	VHC
#51	AnnotatorNotes T59	C0220847; hepatitis C virus; Virus
T60	LIVB 455 464	Pacientes
#52	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Duration 479 486	crónica
#53	AnnotatorNotes T61	C0205191; chronic; Temporal Concept
T62	LIVB 491 494	VHC
#54	AnnotatorNotes T62	C0220847; hepatitis C virus; Virus
T63	PROC 495 503	genotipo
#55	AnnotatorNotes T63	C1285573; Genotype determination; Laboratory Procedure
T65	LIVB 606 615	pacientes
#56	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	Neg_cue 616 618	NO
T68	LIVB 928 931	VHD
#57	AnnotatorNotes T68	C0011220; Hepatitis Delta Virus; Virus
T74	Date 1102 1108	actual
T76	LIVB 1287 1296	Pacientes
#58	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T77	LIVB 1333 1342	Pacientes
#59	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T80	LIVB 1477 1489	investigador
#60	AnnotatorNotes T80	C0035173; Research Personnel; Professional or Occupational Group
T82	Duration 1729 1740	los 60 días
T83	Neg_cue 1799 1815	Incapacidad para
T84	PHYS 111 139	FUNCIÓN GLOMERULAR Y TUBULAR
#61	AnnotatorNotes T84	C0678874; glomerular function; Organ or Tissue Function + C0678875; renal tubular function; Organ or Tissue Function
T85	PHYS 320 348	FUNCIÓN GLOMERULAR Y TUBULAR
#62	AnnotatorNotes T85	C0678874; glomerular function; Organ or Tissue Function + C0678875; renal tubular function; Organ or Tissue Function
T64	Age 680 693	superior a 18
T67	ANAT 707 717	glomerular
#63	AnnotatorNotes T67	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Assertion T14 Negated
A2	Assertion T40 Negated
A3	Status T20 History_of
A4	Status T21 History_of
A5	Status T22 History_of
A6	Status T23 History_of
A7	Status T31 History_of
A8	Status T38 History_of
#64	AnnotatorNotes T5	C1096776; Multicenter Study; Research Activity + C0008976; Clinical Trials; Research Activity
#65	AnnotatorNotes T19	C0019196; Hepatitis C; Disease or Syndrome
#66	AnnotatorNotes T74	C0521116; Current (present time); Temporal Concept 
T69	Spec_cue 1642 1650	pudieran
T70	Observation 1651 1672	influir negativamente
A9	Assertion T70 Speculated
R1	Negation Arg1:T83 Arg2:T40	
R2	Speculation Arg1:T69 Arg2:T70	
T71	Food 1236 1243	alcohol
#67	AnnotatorNotes T71	C0001967; Alcoholic Beverages; Food
T72	Food 1276 1283	alcohol
#68	AnnotatorNotes T72	C0001967; Alcoholic Beverages; Food
R3	Used_for Arg1:T2 Arg2:T1	
R4	Location_of Arg1:T3 Arg2:T84	
R5	Experiences Arg1:T54 Arg2:T1	
R6	Experiences Arg1:T54 Arg2:T84	
R7	Experiences Arg1:T54 Arg2:T4	
R8	Has_Duration_or_Interval Arg1:T4 Arg2:T55	
R9	Causes Arg1:T56 Arg2:T4	
R10	Used_for Arg1:T7 Arg2:T6	
R11	Location_of Arg1:T8 Arg2:T85	
R12	Experiences Arg1:T57 Arg2:T6	
R13	Experiences Arg1:T57 Arg2:T85	
R14	Experiences Arg1:T57 Arg2:T9	
R15	Has_Duration_or_Interval Arg1:T9 Arg2:T58	
R16	Causes Arg1:T59 Arg2:T9	
R17	Has_Duration_or_Interval Arg1:T11 Arg2:T61	
R18	Causes Arg1:T62 Arg2:T11	
R19	Experiences Arg1:T60 Arg2:T11	
R20	Experiences Arg1:T60 Arg2:T63	
R21	Experiences Arg1:T60 Arg2:T12	
R22	Overlap Arg1:T11 Arg2:T12	
R23	Experiences Arg1:T60 Arg2:T30	
R24	Experiences Arg1:T65 Arg2:T14	
R25	Used_for Arg1:T14 Arg2:T34	
R26	Negation Arg1:T66 Arg2:T14	
R27	Combined_with Arg1:T13 Arg2:T51	
R28	Experiences Arg1:T60 Arg2:T13	
R29	Location_of Arg1:T67 Arg2:T15	
T73	Result_or_Value 724 744	superior a 30 ml/min
R30	Has_Result_or_Value Arg1:T15 Arg2:T73	
T75	Quantifier_or_Qualifier 718 723	basal
#69	AnnotatorNotes T75	C1442488; Baseline; Quantitative Concept
R31	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T75	
T78	CONC 793 796	ICH
#70	AnnotatorNotes T78	C4684685; ICH Common Technical Document; Intellectual Product
T79	CONC 797 800	GCP
#71	AnnotatorNotes T79	C5235445; GCP Adherence Statement; Intellectual Product
R32	Before Arg1:T33 Arg2:T16	
R33	Causes Arg1:T68 Arg2:T17	
T81	Result_or_Value 1036 1040	> 14
R34	Has_Result_or_Value Arg1:T45 Arg2:T81	
R35	Overlap Arg1:T20 Arg2:T74	
R36	Overlap Arg1:T21 Arg2:T74	
R37	Overlap Arg1:T22 Arg2:T74	
R38	Overlap Arg1:T23 Arg2:T74	
R39	Location_of Arg1:T43 Arg2:T26	
R40	Location_of Arg1:T43 Arg2:T25	
#72	AnnotatorNotes T44	C4273278; alcohol use behavior; Finding | C5428797; finding of alcohol drinking behavior; Finding
T86	Result_or_Value 1244 1283	igual o superior a 50 gramos de alcohol
R41	Has_Result_or_Value Arg1:T44 Arg2:T86	
R42	Location_of Arg1:T46 Arg2:T31	
R43	Experiences Arg1:T76 Arg2:T31	
R44	Experiences Arg1:T77 Arg2:T32	
R45	Experiences Arg1:T77 Arg2:T47	
R46	Experiences Arg1:T77 Arg2:T48	
R47	Experiences Arg1:T77 Arg2:T49	
T87	Result_or_Value 1357 1364	<50.000
R48	Has_Result_or_Value Arg1:T32 Arg2:T87	
T88	Result_or_Value 1378 1387	<10 gr/dl
R49	Has_Result_or_Value Arg1:T47 Arg2:T88	
T89	Result_or_Value 1398 1405	<3 gr/l
R50	Has_Result_or_Value Arg1:T48 Arg2:T89	
T90	Result_or_Value 1419 1423	>2,5
R51	Has_Result_or_Value Arg1:T49 Arg2:T90	
T91	Observation 1498 1532	hallazgos en la exploración física
T92	Observation 1534 1586	anomalías en los resultados de los análisis clínicos
#73	AnnotatorNotes T92	C3648370; laboratory tests nonspecific abnormal findings; Finding
T93	Observation 1595 1637	factores médicos, sociales o psicosociales
R54	Before Arg1:T91 Arg2:T70	
R55	Before Arg1:T92 Arg2:T70	
R56	Before Arg1:T93 Arg2:T70	
R57	Overlap Arg1:T38 Arg2:T82	
R58	Before Arg1:T38 Arg2:T50	
R59	Used_for Arg1:T39 Arg2:T50	
#74	AnnotatorNotes T34	C1276413; Therapeutic regimen; Therapeutic or Preventive Procedure
#75	AnnotatorNotes T91	C0311392; Physical findings; Finding
#76	AnnotatorNotes T18	C0011226; Hepatitis D Infection; Disease or Syndrome
A10	Assertion T91 Hypothetical
A11	Assertion T92 Hypothetical
A12	Assertion T93 Hypothetical
A13	Experiencer T80 Other
A14	Experiencer T77 Patient
A15	Experiencer T76 Patient
A16	Experiencer T54 Patient
A17	Experiencer T57 Patient
A18	Experiencer T60 Patient
A19	Experiencer T65 Patient
